Transplant Diagnostics Market, by Product Type (Instrument, Reagents & Kits, and Software), by Technology (Molecular Assay, and Non-Molecular Assay), by Application (Tissue Typing, Infectious Disease Testing, Serum-Cross Matching, and Blood Profiling), by Organ Type (Kidney, Liver, Heart, Lungs, Pancreas, and Others), by End User (Hospitals & Transplant Centers, Research Laboratories & Academic Institutes, and Commercial Service Providers) and Region - Global Trends, and Forecast to 2025

Transplant Diagnostics Market - Insights

Transplant diagnostics involves assessment of aspects associated with a transplant such as compatibility testing, safety testing, and transplant feasibility testing pre-, peri-, and post transplantation. Depending on the source of the transplant organ, they are categorized into autografts, allograft, and xenograft. Auto graft is transfer of cells, tissues, and organs within same the individual; allograft is transfer of organs or tissues from one individual to another from same species; whereas, xenograft involves transfer of tissues and organs between two different species. Allograft and xenograft transplantation involves intensive testing of donor as well as receiver, physiological parameters in order to successfully match the donor organ and receiver body and prepare contingencies for future problems. Issues associated with organ transplantation such as acute rejection can be avoided by using advanced transplant diagnostic techniques. Development of new transcriptomic, genomic, and proteomic biomarkers in molecular diagnostics can provide better personalized management for organ transplantation and can detect rejection episodes early.  

Advancement in technology in diagnostics is expected to drive growth of the transplant diagnostics market

Advent of new diagnostic tests have improved medical outcomes associated with organ transplants. Organ rejection rate can be minimized by matching the donor and recipient compatibility before transplantation. Conventional techniques in transplant diagnostics include analysis of human leukocyte antigen (HLA). HLA analysis is done in high-throughput laboratories with a limited staff, which is time consuming. However, presence of molecular assay technologies, such as sequencing techniques and PCR-based assays have proved to be efficient. Genetic information can be interpreted on a large scale by using advanced next generation sequencing (NGS) technologies at an affordable price. For instance, Illumina’s MiSeq system offers high-resolution HLA typing and uses next generation sequencing technology, which can be used by any laboratory. In December 2015, Immucor and Sirona Genomics introduced MIA FORA NGS—a high-resolution HLA typing solution—that provides accurate and detailed coverage of 11 HLA genes. Furthermore, HLA analysis at the DNA level is possible due to technologies such as PCR-RFLP, PCR-SSP, PCR-SSO, PCR-SSCP, and PCR-SNP.

The global transplant diagnostics market was valued at US$ 544.2 million in 2016 and is expected to witness a robust CAGR of 8.4% over the forecast period (2017–2025).

Figure 1. Global Transplant Diagnostics Market, Regional Share, 2016

transplant diagnostics market

Source: Coherent Market Insights Analysis (2018)

Government initiatives to promote organ transplantation along with awareness initiatives for the same is supporting growth of the transplant diagnostics market

Increasing number of transplantation is expected to increase demand for transplant diagnostics, in order to reduce episodes of organ rejection. Various organizations such as World Health Organization (WHO) and World Health Assembly have implanted action plans such as WHA57.18 to increase awareness regarding transplantation. National Health Service (NHS) Blood & Transplant funded a living transplant initiative in 2016, which was led by the National BAME Transplant Alliance, to increase the number of living transplants from black, Asian, and minority ethnic (BAME) communities. Moreover, in 2015, the Health Resources and Services Administration in the U.S. initiated the Organ Donation and Transplantation Funding program and allocated US$ 24 million for research. Similarly, government in the U.K. allocated a budget of US$ 28 billion in FY2015, of which US$ 1.85 million was invested in medical research of HLA diagnosis conducted by universities and institutes. Furthermore, National Organ & Tissue Transplant Organization (NOTTO), India, keeps a track of transplant activities and organizes awareness activities and programs in the country.

However, transplant diagnostic products are costly, and despite continuous efforts from government organizations to promote organ donation, there is reluctance for organ donation which is restraining the growth of the transplant diagnostics market. 

Some major players operating in the transplant diagnostics market are Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Qiagen N.V., F. Hoffman-La Roche Ltd., Immucor, Inc., Becton Dickinson and Company, bioMérieux S.A., Illumina, Inc., CareDx, Inc., and GenDx.

Transplant diagnostics involves assessing compatibility between organ donor and receiver so as to predict any future organ rejection episodes and have contingencies in place. Number of tests are performed such as ABO blood group compatibility, tissue typing, cross matching, panel reactive antibody test, serology screening, and testing for infectious diseases. Increased understanding of the organ rejection phenomenon has led to identification of robust biomarkers along with development of robust biomarker identification tests. Technological advancements in the molecular and non-molecular assays such as PCR, and NGS has increased the data throughput. However, high cost of transplant diagnostic products, limited medical reimbursement, and low awareness about organ transplantation in emerging economies such as Middle East and Asia Pacific is expected to be a factor hindering the transplant diagnostics market growth.

Market Dynamics

Rising prevalence of chronic diseases leading to multiple organ failures; benefits offered by transplant diagnostics, which can predict organ rejection episodes and help in preparing a contingency plan; increasing government initiatives for organ donation awareness; and research and development by leading players to enhance transplant diagnostic products is expected to boost growth of the transplant diagnostics market over the forecast period. For instance, Natera, Inc. and University of California, San Francisco (UCSF), announced a research collaboration in 2016, to study DNA markers of Kidney Transplant Rejection. Furthermore, in 2016, the U.S. government announced plans to invest US$ 200 million to shorten the waiting list of organ transplant patients. These factors are expected to aid in growth of the market over the forecast period.

Key features of the study:

  • This report provides in-depth analysis of transplant diagnostics market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017–2025), considering 2016 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global transplant diagnostics market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key companies covered as a part of this study include Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Qiagen N.V., F. Hoffman-La Roche Ltd., Immucor, Inc., Becton Dickinson and Company, bioMérieux S.A., Illumina, Inc., CareDx, Inc., and GenDx.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global transplant diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the transplant diagnostics market

Detailed Segmentation:

  • Global Transplant Diagnostics Market, By Product Type:
    • Instrument
    • Reagents & Kits
    • Software
  • Global Transplant Diagnostics Market, By Technology:
    • Molecular Assay
      • PCR-Based
        • Real Time PCR
        • Sequence Specific Primer (SSP) PCR
        • Sequence Specific Oligonucleotide (SSO) PCR
        • Others
      • Sequencing Based
        • Sanger’s Sequencing
        • Next Generation Sequencing (NGS)
        • Others
    • Non-Molecular Assay
      • Serological Assay
      • Mixed Lymphocyte Culture (MLC) Testing
      • Flow Cytometry
  • Global Transplant Diagnostics Market, By Application:
    • Tissue Typing
    • Infectious Disease Testing
    • Serum-Cross Matching
    • Blood Profiling
  • Global Transplant Diagnostics Market, By Organ Type:
    • Kidney
    • Liver
    • Heart
    • Lungs
    • Pancreas
    • Others
  • Global Transplant Diagnostics Market, By End User:
    • Hospitals & Transplant Centers
    • Research Laboratories & Academic Institutes
    • Commercial Service Providers
  • Global Transplant Diagnostics Market, By Geography:
    • North America
      • By Product Type:
        • Instrument
        • Reagents & Kits
        • Software
      • By Technology:
        • Molecular Assay
          • PCR-Based
            • Real Time PCR
            • Sequence Specific Primer (SSP) PCR
            • Sequence Specific Oligonucleotide (SSO) PCR
            • Others
          • Sequencing Based
            • Sanger’s Sequencing
            • Next Generation Sequencing (NGS)
            • Others
        • Non-Molecular Assay
          • Serological Assay
          • Mixed Lymphocyte Culture (MLC)
          • Flow Cytometry     
      • By Application:
        • Tissue Typing
        • Infectious Disease Testing
        • Serum-Cross Matching
        • Blood Profiling
      • By Organ Type:
        • Kidney
        • Liver
        • Heart
        • Lungs
        • Pancreas
        • Others
      • By End User:
        • Hospitals & Transplant Centers
        • Research Laboratories & Academic Institutes
        • Commercial Service Providers
      • By Country:
        • U.S.
        • Canada
    • Europe
      • By Product Type:
        • Instrument
        • Reagents & Kits
        • Software
      • By Technology:
        • Molecular Assay
          • PCR-Based
            • Real Time PCR
            • Sequence Specific Primer (SSP) PCR
            • Sequence Specific Oligonucleotide (SSO) PCR
            • Others
          • Sequencing Based
            • Sanger’s Sequencing
            • Next Generation Sequencing (NGS)
            • Others
        • Non-Molecular Assay
          • Serological Assay
          • Mixed Lymphocyte Culture (MLC)
          • Flow Cytometry     
      • By Application:
        • Tissue Typing
        • Infectious Disease Testing
        • Serum-Cross Matching
        • Blood Profiling
      • By Organ Type:
        • Kidney
        • Liver
        • Heart
        • Lungs
        • Pancreas
        • Others
      • By End User:
        • Hospitals & Transplant Centers
        • Research Laboratories & Academic Institutes
        • Commercial Service Providers
      • By Country:
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Product Type:
        • Instrument
        • Reagents & Kits
        • Software
      • By Technology:
        • Molecular Assay
          • PCR-Based
            • Real Time PCR
            • Sequence Specific Primer (SSP) PCR
            • Sequence Specific Oligonucleotide (SSO) PCR
            • Others
          • Sequencing Based
            • Sanger’s Sequencing
            • Next Generation Sequencing (NGS)
            • Others
        • Non-Molecular Assay
          • Serological Assay
          • Mixed Lymphocyte Culture (MLC)
          • Flow Cytometry     
      • By Application:
        • Tissue Typing
        • Infectious Disease Testing
        • Serum-Cross Matching
        • Blood Profiling
      • By Organ Type:
        • Kidney
        • Liver
        • Heart
        • Lungs
        • Pancreas
        • Others
      • By End User:
        • Hospitals & Transplant Centers
        • Research Laboratories & Academic Institutes
        • Commercial Service Providers
      • By Country:
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • By Product Type:
        • Instrument
        • Reagents & Kits
        • Software
      • By Technology:
        • Molecular Assay
          • PCR-Based
            • Real Time PCR
            • Sequence Specific Primer (SSP) PCR
            • Sequence Specific Oligonucleotide (SSO) PCR
            • Others
          • Sequencing Based
            • Sanger’s Sequencing
            • Next Generation Sequencing (NGS)
            • Others
        • Non-Molecular Assay
          • Serological Assay
          • Mixed Lymphocyte Culture (MLC)
          • Flow Cytometry     
      • By Application:
        • Tissue Typing
        • Infectious Disease Testing
        • Serum-Cross Matching
        • Blood Profiling
      • By Organ Type:
        • Kidney
        • Liver
        • Heart
        • Lungs
        • Pancreas
        • Others
      • By End User:
        • Hospitals & Transplant Centers
        • Research Laboratories & Academic Institutes
        • Commercial Service Providers
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East
      • By Product Type:
        • Instrument
        • Reagents & Kits
        • Software
      • By Technology:
        • Molecular Assay
          • PCR-Based
            • Real Time PCR
            • Sequence Specific Primer (SSP) PCR
            • Sequence Specific Oligonucleotide (SSO) PCR
            • Others
          • Sequencing Based
            • Sanger’s Sequencing
            • Next Generation Sequencing (NGS)
            • Others
        • Non-Molecular Assay
          • Serological Assay
          • Mixed Lymphocyte Culture (MLC)
          • Flow Cytometry     
      • By Application:
        • Tissue Typing
        • Infectious Disease Testing
        • Serum-Cross Matching
        • Blood Profiling
      • By Organ Type:
        • Kidney
        • Liver
        • Heart
        • Lungs
        • Pancreas
        • Others
      • By End User:
        • Hospitals & Transplant Centers
        • Research Laboratories & Academic Institutes
        • Commercial Service Providers
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Product Type:
        • Instrument
        • Reagents & Kits
        • Software
      • By Technology:
        • Molecular Assay
          • PCR-Based
            • Real Time PCR
            • Sequence Specific Primer (SSP) PCR
            • Sequence Specific Oligonucleotide (SSO) PCR
            • Others
          • Sequencing Based
            • Sanger’s Sequencing
            • Next Generation Sequencing (NGS)
            • Others
        • Non-Molecular Assay
          • Serological Assay
          • Mixed Lymphocyte Culture (MLC)
          • Flow Cytometry     
      • By Application:
        • Tissue Typing
        • Infectious Disease Testing
        • Serum-Cross Matching
        • Blood Profiling
      • By Organ Type:
        • Kidney
        • Liver
        • Heart
        • Lungs
        • Pancreas
        • Others
      • By End User:
        • Hospitals & Transplant Centers
        • Research Laboratories & Academic Institutes
        • Commercial Service Providers
      • By Country:
        • Central Africa
        • South Africa
        • North Africa
  • Company Profiles
    • Thermo Fisher Scientific, Inc.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
    • Bio-Rad Laboratories, Inc.
    • Qiagen N.V.
    • Hoffman-La Roche Ltd.
    • Immucor, Inc.
    • Becton Dickinson and Company
    • BioMérieux S.A.
    • Illumina, Inc.
    • CareDx, Inc.
    • GenDx

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Technology
      • Market Snippet, By Application
      • Market Snippet, By Organ Type
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • PEST Analysis
    • PORTER’s Five Forces Analysis
    • Regulatory Scenario
    • Technological Evolution
  4. Global Transplant Diagnostics Market, By Product Type, 2017–2025 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, 2016–2025
      • Segment Trends
    • Instrument
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
    • Reagents & Kits
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
    • Software
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
  5. Global Transplant Diagnostics Market, By Technology, 2017–2025 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, 2016–2025
      • Segment Trends
    • Molecular Assay
      • PCR-Based
        • Introduction
        • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
          • Real Time PCR
          • Sequence Specific Primer (SSP) PCR
          • Sequence Specific Oligonucleotide (SSO) PCR
          • Others
      • Sequencing Based
        • Introduction
        • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
          • Sanger’s Sequencing
          • Next Generation Sequencing (NGS)
          • Others
    • Non-Molecular Assay
      • Serological Assay
        • Introduction
        • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
      • Mixed Lymphocyte Culture (MLC) Testing
        • Introduction
        • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
      • Flow Cytometry
        • Introduction
        • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
  6. Global Transplant Diagnostics Market, By Application, 2017–2025 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, 2016–2025
      • Segment Trends
    • Tissue Typing
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
    • Infectious Disease Testing
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
    • Serum-Cross Matching
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
    • Blood Profiling
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
  7. Global Transplant Diagnostics Market, By Organ Type, 2017–2025 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, 2016–2025
      • Segment Trends
    • Kidney
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
    • Liver
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
    • Heart
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
    • Lungs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
    • Pancreas
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
  8. Global Transplant Diagnostics Market, By End User, 2017–2025 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, 2016–2025
      • Segment Trends
    • Hospitals & Transplant Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
    • Research Laboratories & Academic Institutes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
    • Commercial Service Providers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
  9. Global Transplant Diagnostics Market, By Region, 2017–2025 (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2025
    • North America
      • Market Size and Forecast, By Product Type, 2017–2025 (US$ Mn)
      • Market Size and Forecast, By Technology, 2017–2025 (US$ Mn)
      • Market Size and Forecast, By Application, 2017–2025 (US$ Mn)
      • Market Size and Forecast, By Organ Type, 2017–2025 (US$ Mn)
      • Market Size and Forecast, By End User, 2017–2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2017–2025 (US$ Mn)
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast, By Product Type, 2017–2025 (US$ Mn)
      • Market Size and Forecast, By Technology, 2017–2025 (US$ Mn)
      • Market Size and Forecast, By Application, 2017–2025 (US$ Mn)
      • Market Size and Forecast, By Organ Type, 2017–2025 (US$ Mn)
      • Market Size and Forecast, By End User, 2017–2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2017–2025 (US$ Mn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Product Type, 2017–2025 (US$ Mn)
      • Market Size and Forecast, By Technology, 2017–2025 (US$ Mn)
      • Market Size and Forecast, By Application, 2017–2025 (US$ Mn)
      • Market Size and Forecast, By Organ Type, 2017–2025 (US$ Mn)
      • Market Size and Forecast, By End User, 2017–2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2017–2025 (US$ Mn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of APAC
    • Latin America
      • Market Size and Forecast, By Product Type, 2017–2025 (US$ Mn)
      • Market Size and Forecast, By Technology, 2017–2025 (US$ Mn)
      • Market Size and Forecast, By Application, 2017–2025 (US$ Mn)
      • Market Size and Forecast, By Organ Type, 2017–2025 (US$ Mn)
      • Market Size and Forecast, By End User, 2017–2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2017–2025 (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Africa
      • Market Size and Forecast, By Product Type, 2017–2025 (US$ Mn)
      • Market Size and Forecast, By Technology, 2017–2025 (US$ Mn)
      • Market Size and Forecast, By Application, 2017–2025 (US$ Mn)
      • Market Size and Forecast, By Organ Type, 2017–2025 (US$ Mn)
      • Market Size and Forecast, By End User, 2017–2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2017–2025 (US$ Mn)
        • Central Africa
        • South Africa
        • North Africa
    • Middle East
      • Market Size and Forecast, By Product Type, 2017–2025 (US$ Mn)
      • Market Size and Forecast, By Technology, 2017–2025 (US$ Mn)
      • Market Size and Forecast, By Application, 2017–2025 (US$ Mn)
      • Market Size and Forecast, By Organ Type, 2017–2025 (US$ Mn)
      • Market Size and Forecast, By End User, 2017–2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2017–2025 (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
  10. Competitive Landscape
    • Heat Map Analysis
    • Company Profiles
      • Thermo Fisher Scientific, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Bio-Rad Laboratories, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Qiagen N.V.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Hoffman-La Roche Ltd.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Immucor, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Becton Dickinson and Company
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • BioMérieux S.A.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Illumina, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • CareDx
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • GenDx
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
  11. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 48 market data tables and 37 figures on "Transplant Diagnostics Market - Global forecast to 2025”.

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.


Smiley face

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.

Smiley face

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization:

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.